| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Mahendra Shah last filed a Form 4 in June 2024, as Director at BOLT. The filings on record cover 3 companies. Mahendra Shah's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,159,742 shares of QTTB.
Mahendra Shah has 14 Form 4 filings on record from March 2017 to June 2024, across 3 companies: Director at Bolt Biotherapeutics (BOLT), 2021–2024; Director at Soleno Therapeutics (SLNO), 2017–2018; Director at QTTB, 2018.
The 19 reported transactions were 8 option or other derivative awards, 6 stock awards, 3 conversions and 1 option exercise, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $1K.
The only open-market sale was 62 shares of BOLT at an average $20.00 on February 9, 2021, about $1K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Director | Sell | 62 | $20.00 | $1,240.00 | - |